These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 17073665)
1. Mechanosensitive channels: therapeutic targets in the myocardium? White E Curr Pharm Des; 2006; 12(28):3645-63. PubMed ID: 17073665 [TBL] [Abstract][Full Text] [Related]
2. Mechanosensitive ion channels as drug targets. Gottlieb PA; Suchyna TM; Ostrow LW; Sachs F Curr Drug Targets CNS Neurol Disord; 2004 Aug; 3(4):287-95. PubMed ID: 15379605 [TBL] [Abstract][Full Text] [Related]
3. The role of stretch-activated channels in atrial fibrillation and the impact of intracellular acidosis. Ninio DM; Saint DA Prog Biophys Mol Biol; 2008; 97(2-3):401-16. PubMed ID: 18367236 [TBL] [Abstract][Full Text] [Related]
4. Solution structure of peptide toxins that block mechanosensitive ion channels. Oswald RE; Suchyna TM; McFeeters R; Gottlieb P; Sachs F J Biol Chem; 2002 Sep; 277(37):34443-50. PubMed ID: 12082099 [TBL] [Abstract][Full Text] [Related]
5. Mechanosensitive ion channels and the peptide inhibitor GsMTx-4: history, properties, mechanisms and pharmacology. Bowman CL; Gottlieb PA; Suchyna TM; Murphy YK; Sachs F Toxicon; 2007 Feb; 49(2):249-70. PubMed ID: 17157345 [TBL] [Abstract][Full Text] [Related]
6. Channel-specific therapy of cardiac arrhythmias in our time? Fozzard HA J Cardiovasc Electrophysiol; 2000 Mar; 11(3):369-70. PubMed ID: 10749361 [No Abstract] [Full Text] [Related]
8. [A new mechanosensitive channel SAKCA and a new MS channel blocker GsTMx-4]. Sokabe M; Naruse K; Qiong-Yao T Nihon Yakurigaku Zasshi; 2004 Nov; 124(5):301-10. PubMed ID: 15502395 [TBL] [Abstract][Full Text] [Related]
9. Mechano-electrical feedback underlying arrhythmias: the atrial fibrillation case. Franz MR; Bode F Prog Biophys Mol Biol; 2003; 82(1-3):163-74. PubMed ID: 12732276 [TBL] [Abstract][Full Text] [Related]
10. The cardiac sarcolemmal ATP-sensitive potassium channel as a novel target for anti-arrhythmic therapy. Billman GE Pharmacol Ther; 2008 Oct; 120(1):54-70. PubMed ID: 18708091 [TBL] [Abstract][Full Text] [Related]
11. ["Sicilian gambit": pathophysiological approach to drug therapy of arrhythmia (lecture]]. Sulimov VA Ter Arkh; 1999; 71(8):67-74. PubMed ID: 10515042 [No Abstract] [Full Text] [Related]
12. Two types of peptides derived from the neurotoxin GsMTx4 inhibit a mechanosensitive potassium channel by modifying the mechanogate. Zhou N; Li H; Xu J; Shen ZS; Tang M; Wang XH; Su WX; Sokabe M; Zhang Z; Tang QY J Biol Chem; 2022 Sep; 298(9):102326. PubMed ID: 35933015 [TBL] [Abstract][Full Text] [Related]
13. Cardiac sodium channels and inherited electrophysiological disorders: an update on the pharmacotherapy. van Hoeijen DA; Blom MT; Tan HL Expert Opin Pharmacother; 2014 Sep; 15(13):1875-87. PubMed ID: 24992280 [TBL] [Abstract][Full Text] [Related]
14. [Current concepts of the ionic mechanisms of cardiac arrhythmias and the possible mechanisms of action of cardiac anti-arrhythmia agents]. Porotikov VI; Lazarev AV; Glezer GA Usp Fiziol Nauk; 1984; 15(3):42-63. PubMed ID: 6089463 [No Abstract] [Full Text] [Related]
15. Effects of zacopride, a moderate I Elnakish MT; Canan BD; Kilic A; Mohler PJ; Janssen PM Pharmacol Res; 2017 Jan; 115():309-318. PubMed ID: 27914945 [TBL] [Abstract][Full Text] [Related]
16. [Comparative characteristic of sodium blocking properties of anti-arrhythmia agents on isolated rats cardiomyocytes]. Khankoeva AI; Dukhanin AS; Galenko-Iaroshevskií PA Biull Eksp Biol Med; 1997 Jun; 123(6):666-8. PubMed ID: 9280522 [No Abstract] [Full Text] [Related]